169 related articles for article (PubMed ID: 9500438)
1. BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability.
Gretarsdottir S; Thorlacius S; Valgardsdottir R; Gudlaugsdottir S; Sigurdsson S; Steinarsdottir M; Jonasson JG; Anamthawat-Jonsson K; Eyfjörd JE
Cancer Res; 1998 Mar; 58(5):859-62. PubMed ID: 9500438
[TBL] [Abstract][Full Text] [Related]
2. p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours.
Crook T; Brooks LA; Crossland S; Osin P; Barker KT; Waller J; Philp E; Smith PD; Yulug I; Peto J; Parker G; Allday MJ; Crompton MR; Gusterson BA
Oncogene; 1998 Oct; 17(13):1681-9. PubMed ID: 9796697
[TBL] [Abstract][Full Text] [Related]
3. TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution.
Greenblatt MS; Chappuis PO; Bond JP; Hamel N; Foulkes WD
Cancer Res; 2001 May; 61(10):4092-7. PubMed ID: 11358831
[TBL] [Abstract][Full Text] [Related]
4. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.
Eiriksdottir G; Barkardottir RB; Agnarsson BA; Johannesdottir G; Olafsdottir K; Egilsson V; Ingvarsson S
Oncogene; 1998 Jan; 16(1):21-6. PubMed ID: 9467939
[TBL] [Abstract][Full Text] [Related]
5. Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in BRCA2 mutation carriers.
Savelyeva L; Claas A; Matzner I; Schlag P; Hofmann W; Scherneck S; Weber B; Schwab M
Cancer Res; 2001 Jul; 61(13):5179-85. PubMed ID: 11431357
[TBL] [Abstract][Full Text] [Related]
6. High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutation.
Ingvarsson S; Geirsdottir EK; Johannesdottir G; Sigbjörnsdóttir BI; Eiriksdottir G; Ragnarsson G; Agnarsson BA; Gudmundsson J; Jonasson JG; Sigurdsson A; Egilsson V; Barkardottir RB
Cancer Res; 1998 Oct; 58(19):4421-5. PubMed ID: 9766673
[TBL] [Abstract][Full Text] [Related]
7. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
[TBL] [Abstract][Full Text] [Related]
9. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.
Armes JE; Trute L; White D; Southey MC; Hammet F; Tesoriero A; Hutchins AM; Dite GS; McCredie MR; Giles GG; Hopper JL; Venter DJ
Cancer Res; 1999 Apr; 59(8):2011-7. PubMed ID: 10213514
[TBL] [Abstract][Full Text] [Related]
10. BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease.
Haraldsson K; Loman N; Zhang QX; Johannsson O; Olsson H; Borg A
Cancer Res; 1998 Apr; 58(7):1367-71. PubMed ID: 9537231
[TBL] [Abstract][Full Text] [Related]
11. The Brca1 and Brca2 proteins and tumor pathogenesis.
Ingvarsson S
Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation.
Connor F; Bertwistle D; Mee PJ; Ross GM; Swift S; Grigorieva E; Tybulewicz VL; Ashworth A
Nat Genet; 1997 Dec; 17(4):423-30. PubMed ID: 9398843
[TBL] [Abstract][Full Text] [Related]
13. BRCA-associated breast cancer: absence of a characteristic immunophenotype.
Robson M; Rajan P; Rosen PP; Gilewski T; Hirschaut Y; Pressman P; Haas B; Norton L; Offit K
Cancer Res; 1998 May; 58(9):1839-42. PubMed ID: 9581822
[TBL] [Abstract][Full Text] [Related]
14. BRCA2 germline mutations in Swedish breast cancer families.
Chen J; Hedman MZ; Arver BW; Sigurdsson S; Eyfjörd JE; Lindblom A
Eur J Hum Genet; 1998; 6(2):134-9. PubMed ID: 9781057
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 and BRCA2 gene mutation analysis: visit to the Breast Cancer Information Core (BIC).
Shen D; Vadgama JV
Oncol Res; 1999; 11(2):63-9. PubMed ID: 10489161
[TBL] [Abstract][Full Text] [Related]
16. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
[TBL] [Abstract][Full Text] [Related]
17. Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer.
Hamann U; Herbold C; Costa S; Solomayer EF; Kaufmann M; Bastert G; Ulmer HU; Frenzel H; Komitowski D
Cancer Res; 1996 May; 56(9):1988-90. PubMed ID: 8616837
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers.
Shih HA; Nathanson KL; Seal S; Collins N; Stratton MR; Rebbeck TR; Weber BL
Clin Cancer Res; 2000 Nov; 6(11):4259-64. PubMed ID: 11106241
[TBL] [Abstract][Full Text] [Related]
19. [Pregnancy and risk of early breast cancer in patients sith BRCA1 and BRCA2 mutations].
Ost E; Illiger HJ
Strahlenther Onkol; 2000 Jul; 176(7):335-6. PubMed ID: 10963002
[No Abstract] [Full Text] [Related]
20. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
Hopper JL; Southey MC; Dite GS; Jolley DJ; Giles GG; McCredie MR; Easton DF; Venter DJ
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):741-7. PubMed ID: 10498392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]